Synthesis of bivalent β2-adrenergic and adenosine A1 receptor ligands

被引:25
|
作者
Karellas, Peter [2 ,3 ]
McNaughton, Michael [2 ]
Baker, Stephen P. [1 ]
Scammells, Peter J. [2 ]
机构
[1] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
[2] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia
[3] Starpharma Pty Ltd, Melbourne, Vic, Australia
关键词
D O I
10.1021/jm800613s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Research in the area of simutaneously targeting more than one G protein-coupled receptor (GPCR) has increased in recent times. By exploiting the cross talk between the beta(2)-adrenergic (beta(2)AR) and adenosine A(1) receptors (A(1)AR) on adenylate cyclase activity, we synthesized a series of bivalent agonists for both GPCRs to generate responses from more than one receptor. We have demonstrated a relationship between the various beta(2)-adrenergic and A(1) adenosine bivalent parameters of linker and bifunctionality by using data that are drawn from in vitro assays. The hexyl-linked 12e (K-i, 311 nM) and butyl-linked 12c (K-i, 863 nM) bivalent compounds displayed reasonable binding affinities for the PAR when compared with the control (-)isoproterenol (K-i, 136 nM), and both compounds also exhibited a persuasive bifunctional trend for both receptors at various drug concentrations. The bivalent compound 12e was also found to have significant EC50 potency (6 nM) at the beta(2)AR in DDT cells.
引用
收藏
页码:6128 / 6137
页数:10
相关论文
共 50 条
  • [41] β1 and β2-adrenergic receptor gene polymorphisms are not associated with heart failure
    Lavandero, S
    Moraga, F
    Mellado, R
    Chiong, M
    Diaz-Araya, G
    Castro, P
    Greig, D
    Perez, O
    Moreno, M
    FASEB JOURNAL, 2003, 17 (04): : A652 - A652
  • [42] β2-adrenergic receptor polymorphisms and risk of COPD
    Karimi, Leila
    Lahousse, Lies
    Stricker, Bruno H. C.
    Van der Lei, Johan
    Verhamme, Katia M.
    Brusselle, Guy G.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [43] A crystal clear view of the β2-adrenergic receptor
    Lefkowitz, Robert J.
    Sun, Jin-Peng
    Shukla, Arun K.
    NATURE BIOTECHNOLOGY, 2008, 26 (02) : 189 - 191
  • [44] The Dynamic Process of β2-Adrenergic Receptor Activation
    Nygaard, Rie
    Zou, Yaozhong
    Dror, Ron O.
    Mildorf, Thomas J.
    Arlow, Daniel H.
    Manglik, Aashish
    Pan, Albert C.
    Liu, Corey W.
    Fung, Juan Jose
    Bokoch, Michael P.
    Thian, Foon Sun
    Kobilka, Tong Sun
    Shaw, David E.
    Mueller, Luciano
    Prosser, R. Scott
    Kobilka, Brian K.
    CELL, 2013, 152 (03) : 532 - 542
  • [45] β2-Adrenergic receptor genotype and preterm delivery
    Landau, R
    Xie, HG
    Dishy, V
    Stein, CM
    Wood, AJJ
    Moore, JH
    Emala, CW
    Smiley, RM
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 187 (05) : 1294 - 1298
  • [46] Crystallizing thinking about the β2-adrenergic receptor
    Shukla, Arun K.
    Sun, Jin-Peng
    Lefkowitz, Robert J.
    MOLECULAR PHARMACOLOGY, 2008, 73 (05) : 1333 - 1338
  • [47] Polymorphisms of the β2-adrenergic receptor.: Reply
    Dishy, V
    Stein, CM
    Wood, AJJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (07): : 537 - 538
  • [48] Quantification of Ligand Bias for Clinically Relevant β2-Adrenergic Receptor Ligands: Implications for Drug Taxonomy
    van der Westhuizen, Emma T.
    Breton, Billy
    Christopoulos, Arthur
    Bouvier, Michel
    MOLECULAR PHARMACOLOGY, 2014, 85 (03) : 492 - 509
  • [49] βARK1 directs β2-adrenergic receptor to Gi signaling
    Zhu, WZ
    Zhang, SJ
    Koch, WJ
    Xiao, RP
    CIRCULATION, 2005, 112 (17) : U53 - U54
  • [50] Role of arrestins in trafficking of the β2-adrenergic receptor
    Benovic, JL
    Gagnon, AW
    Goodman, OB
    Gurevich, VV
    Kallal, L
    Krupnick, JG
    Penn, RB
    Santini, F
    Keen, JH
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R17 - R17